PharmX Technologies (ASX:PHX) - Cotización, noticias y análisis

Resumen de acción PHX

PharmX Technologies Limited, junto con sus filiales, opera como empresa tecnológica y de desarrollo de software en Australia.

Acerca de la empresa

PHX fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	3/6
Financial Health	6/6
Dividends	0/6

Recompensas

Cotiza un 98.8% por debajo de nuestra estimación de su valor justo

Ha pasado a ser rentable este año

Análisis de riesgos

Alta volatilidad del precio de la acción en los últimos 3 meses

No tiene ingresos significativos (A$6M)

No tiene una capitalización de mercado significativa (A$18M)

Competidores de PharmX Technologies Limited

Connexion Mobility

ASX:CXZ

AU$24.3m

Etherstack

ASX:ESK

AU$32.3m

Reckon

ASX:RKN

AU$61.7m

Orcoda

ASX:ODA

AU$34.7m

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for PharmX Technologies
Historical stock prices
Current Share Price	AU$0.03
52 Week High	AU$0.053
52 Week Low	AU$0.012
Beta	1.4
1 Month Change	-3.23%
3 Month Change	-14.29%
1 Year Change	-21.05%
3 Year Change	-66.29%
5 Year Change	11.11%
Change since IPO	-99.85%

Noticias y actualizaciones recientes

What Is PharmX Technologies Limited's (ASX:PHX) Share Price Doing?

Feb 12

Recent updates

At AU$0.089, Is It Time To Put Corum Group Limited (ASX:COO) On Your Watch List?

Apr 29

Corum Group (ASX:COO) Is Posting Healthy Earnings, But It Is Not All Good News

Mar 02

Corum Group Limited (ASX:COO) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Dec 13

Rentabilidad de los accionistas

	PHX	AU Software	Mercado AU
7D	-3.2%	2.3%	0.03%
1Y	-21.1%	30.2%	4.2%

Rentabilidad vs. Industria: PHX obtuvo unos resultados inferiores a los del sector Australian Software , que el año pasado arrojó un rendimiento del 28.3%.

Rentabilidad vs. Mercado: PHX obtuvo unos resultados inferiores a los del mercado Australian, que fue del 3.9% el año pasado.

Volatilidad de los precios

Is PHX's price volatile compared to industry and market?
PHX volatility
PHX Average Weekly Movement	21.1%
Software Industry Average Movement	8.8%
Market Average Movement	9.0%
10% most volatile stocks in AU Market	17.7%
10% least volatile stocks in AU Market	3.5%

Precio estable de las acciones: El precio de las acciones de PHX ha sido volátil en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de PHX ha aumentado de 14% a 21% en el último año.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
1950	n/a	Tom Culver	pharmx.com.au

PharmX Technologies Limited, junto con sus filiales, opera como empresa de tecnología y desarrollo de software en Australia. La red de la empresa conecta farmacias minoristas y proveedores en Australia y Nueva Zelanda. Opera PharmX, una pasarela electrónica de pedidos de farmacia; y PharmXchange, una plataforma digital de ventas y marketing integrada con PharmX para farmacias y sus proveedores.

Resumen de fundamentos de PharmX Technologies Limited

¿Cómo se comparan los beneficios e ingresos de PharmX Technologies con su capitalización de mercado?
Estadísticas fundamentales de PHX
Capitalización bursátil	AU$17.96m
Beneficios(TTM)	AU$263.00k
Ingresos (TTM)	AU$6.28m

68.3x

Ratio precio-beneficio (PE)

2.9x

Ratio precio-ventas (PS)

¿Está PHX sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de PHX
Ingresos	AU$6.28m
Coste de los ingresos	AU$3.98m
Beneficio bruto	AU$2.30m
Otros gastos	AU$2.04m
Beneficios	AU$263.00k

Últimos beneficios comunicados

Dec 31, 2023

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)	0.00044
Margen bruto	36.61%
Margen de beneficio neto	4.19%
Ratio deuda/patrimonio	0%

¿Cómo se ha desempeñado PHX a largo plazo?

Ver rendimiento histórico y comparativa

Resumen de acción PHX

Recompensas

Análisis de riesgos

Competidores de PharmX Technologies Limited

ASX:CXZ

AU$24.3m

ASX:ESK

AU$32.3m

ASX:RKN

AU$61.7m

ASX:ODA

AU$34.7m

Historial de precios y rendimiento

Noticias y actualizaciones recientes

First half 2024 earnings released: EPS: AU$0 (vs AU$0.001 loss in 1H 2023)

PharmX Technologies Limited to Report First Half, 2024 Results on Feb 23, 2024

Now 27% overvalued

What Is PharmX Technologies Limited's (ASX:PHX) Share Price Doing?

New major risk - Market cap size

New minor risk - Share price stability

Recent updates

First half 2024 earnings released: EPS: AU$0 (vs AU$0.001 loss in 1H 2023)

PharmX Technologies Limited to Report First Half, 2024 Results on Feb 23, 2024

Now 27% overvalued

What Is PharmX Technologies Limited's (ASX:PHX) Share Price Doing?

New major risk - Market cap size

New minor risk - Share price stability

PharmX Technologies Limited Announces the Appointment of Tom Culver as Chief Executive Officer, Effective 20 November 2023

PharmX Technologies Limited Announces the Appointment of Tom Culver as Chief Executive Officer, Effective 20 November 2023

PharmX Technologies Limited, Annual General Meeting, Nov 21, 2023

New major risk - Revenue and earnings growth

Full year 2023 earnings released: AU$0.002 loss per share (vs AU$0 in FY 2022)

Corum Group Limited to Report Fiscal Year 2023 Results on Aug 23, 2023

Jonas Software AUS Pty Ltd entered into an agreement to acquire Corum Health Pty Ltd and Amfac Pty Ltd. from Corum Group Limited (ASX:COO) for AUD 6.3 million.

A Look At The Intrinsic Value Of Corum Group Limited (ASX:COO)

At AU$0.044, Is Corum Group Limited (ASX:COO) Worth Looking At Closely?

First half 2023 earnings released: AU$0.001 loss per share (vs AU$0 in 1H 2022)

No independent directors

Corum Group Limited, Annual General Meeting, Nov 14, 2022

Full year 2022 earnings released: EPS: AU$0 (vs AU$0.002 in FY 2021)

Corum Group Limited Launches Pharmxchange Platform

No independent directors

Zenith Payments Pty Ltd completed the acquisition Real Estate eCommerce business unit of Corum Group Limited from Corum Group Limited (ASX:COO).

First half 2022 earnings: EPS and revenues miss analyst expectations

Corum Group Limited to Report First Half, 2022 Results on Feb 10, 2022

Corum Group Limited Announces Resignation of Julian Sallabank as Managing Director

Zenith Payments Pty Ltd agreed to acquire Real Estate eCommerce business unit of Corum Group Limited from Corum Group Limited (ASX:COO) for AUD 0.5 million.

Is Now The Time To Put Corum Group (ASX:COO) On Your Watchlist?

Full year 2021 earnings released: EPS AU$0.002 (vs AU$0.001 in FY 2020)

At AU$0.089, Is It Time To Put Corum Group Limited (ASX:COO) On Your Watch List?

Corum Group (ASX:COO) Is Posting Healthy Earnings, But It Is Not All Good News

First half 2021 earnings released: EPS AU$0.002 (vs AU$0.001 loss in 1H 2020)

Corum Group Limited to Report First Half, 2021 Results on Feb 24, 2021

Corum Group Limited (ASX:COO) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Corum Group Limited Announces Appointment of Dennis Bastas to the Board of Directors

Corum Group Limited Appoints Eryl Baron as Company Secretary, Effective 3 November 2020

Corum Group Limited Appoints Jayne Shaw to its Board of Directors

Corum Group Limited (ASX:COO) completed the acquisition of remaining 57% stake in PharmX Pty Ltd from Mountaintop Systems Pty. Ltd. and Daleflag Pty Ltd.

Corum Group Limited (ASX:COO) entered into a binding agreement to acquire remaining 57% stake in PharmX Pty Ltd from Mountaintop Systems Pty Ltd and Daleflag Pty Ltd for AUD 7.9 million

Corum Group Limited (ASX:COO) completed the acquisition of an unknown additional minority stake in PharmX Pty Limited from Fred IT Group Pty Ltd.

Rentabilidad de los accionistas

Volatilidad de los precios

Acerca de la empresa

Resumen de fundamentos de PharmX Technologies Limited

68.3x

2.9x

Beneficios e Ingresos